NEURODERM LTD's ticker is and the CUSIP is M74231107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $22,238,000 | +30.1% | 571,667 | 0.0% | 0.18% | +20.8% |
Q2 2017 | $17,093,000 | +12.6% | 571,667 | 0.0% | 0.15% | +20.2% |
Q1 2017 | $15,178,000 | +19.6% | 571,667 | 0.0% | 0.12% | 0.0% |
Q4 2016 | $12,691,000 | +125.1% | 571,667 | +87.4% | 0.12% | +143.1% |
Q3 2016 | $5,639,000 | +13.8% | 305,000 | 0.0% | 0.05% | -1.9% |
Q2 2016 | $4,956,000 | +15.1% | 305,000 | 0.0% | 0.05% | +15.6% |
Q1 2016 | $4,307,000 | -17.2% | 305,000 | 0.0% | 0.04% | +4.7% |
Q4 2015 | $5,200,000 | -17.5% | 305,000 | 0.0% | 0.04% | -25.9% |
Q3 2015 | $6,304,000 | +64.3% | 305,000 | +22.0% | 0.06% | +70.6% |
Q2 2015 | $3,838,000 | +14.4% | 250,000 | 0.0% | 0.03% | +21.4% |
Q1 2015 | $3,355,000 | -4.4% | 250,000 | 0.0% | 0.03% | -22.2% |
Q4 2014 | $3,510,000 | – | 250,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 261,945 | $4,466,000 | 3.96% |
ACUTA CAPITAL PARTNERS, LLC | 477,300 | $8,138,000 | 3.89% |
Avoro Capital Advisors LLC | 520,022 | $8,866,000 | 3.05% |
Redmile Group, LLC | 1,589,261 | $27,097,000 | 2.03% |
NEXTHERA CAPITAL LP | 48,000 | $818,000 | 1.16% |
SCOPIA CAPITAL MANAGEMENT LP | 2,749,038 | $46,871,000 | 0.93% |
SENZAR ASSET MANAGEMENT, LLC | 201,700 | $3,438,985,000 | 0.38% |
Perceptive Advisors | 270,000 | $4,604,000 | 0.34% |
Foresite Capital Management II, LLC | 55,779 | $951,000 | 0.32% |
RA Capital Management | 144,671 | $2,467,000 | 0.24% |